MDMA assisted psychotherapy found to have a large effect for chronic post-traumatic stress disorder

Journal of Psychopharmacology

Volumn 27, Issue 9, 2013, Pages 865-866

  Chabrol, Henri ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; PLACEBO;

CHRONIC DISEASE; CLINICAL EFFECTIVENESS; DRUG EFFECT; DRUG EFFICACY; HUMAN; LETTER; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOTHERAPY; SELF REPORT; SYMPTOMATOLOGY; TREATMENT DURATION; TREATMENT OUTCOME;

FEMALE; HUMANS; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PSYCHOTHERAPY; STRESS DISORDERS, POST-TRAUMATIC;

EID: 84883404149     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881113495119     Document Type: Letter

References (5)

1. Brunner E, Domhof S, Langer F Nonparametric Analysis of Longitudinal Data in Factorial Experiments. New York: Wiley and Sons ; 2002 :
2. Cohen J. A power primer. Psychol Bull. 1992 ; 112: 155-159
3. Mithoefer MC, Wagner MT, Mithoefer AT, et al. The safety and efficacy of (+/-)3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: The first randomized controlled pilot study. J Psychopharmacol. 2011 ; 25: 439-452
4. Mithoefer MC, Wagner MT, Mithoefer AT, et al. Durability of improvement in PTSD symptoms and absence of harmful effects or drug dependency after MDMA-assisted psychotherapy: A prospective long-term follow-up study. J Psychopharmacol. 2013 ; 27: 28-39
5. Oehen P, Traber R, Widmer V, et al. A randomized, controlled pilot study of MDMA (± 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic post-traumatic stress disorder (PTSD). J Psychopharmacol. 2012 ; 27: 40-52